Supernus Pharmaceuticals, Inc. IPO Advisory

IPO Research - IPO Boutique

<< Return Home

Subscribe Now
  IPO Boutique Blog
  FREE IPO Newsletter
IPO Central
  IPO Calendar
  IPO Pipeline
  Track Record
  2017 IPOs
    IPO Pricings
    Industry Breakdown
  2016 IPOs
  2015 IPOs
  2014 IPOs
  2013 IPOs
  2012 IPOs
  Sample IPO
  Rating Scale
  IPO Primer
  Current Week
  Track Record
  2017 Secondaries
  2016 Secondaries
  Secondaries Primer
International publications
quoting IPO Boutique
founder Scott Sweet
General Info
  About Us
  Contact Us
  Site Map

For IPO Boutique's "scale of 1 to 5" BUY rating on Supernus Pharmaceuticals, Inc., and our comprehensive analysis, click the "Buy Market Research" link.
Price Range
Issue Price
Trade Date
Supernus Pharmaceuticals, Inc.SUPN
[ Nasdaq ]
Last trade $12.05 $0.00 $0.006 million11/30/2012
Jeferies & Co., Piper Jaffray, Cowen & Co.
Stifel Nicolaus Weisel, Lazard Capital Markets

Supernus Pharmaceuticals, Inc. Historical Chart - Click chart for current quote

About Supernus Pharmaceuticals, Inc. (adapted from Supernus Pharmaceuticals, Inc. prospectus):
Supernus is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases. They are developing product candidates in neurology and psychiatry to address large market opportunities in epilepsy and attention deficit hyperactivity disorder, or ADHD. Supernus intends to market their product candidates in the United States through their own focused sales force targeting specialty physicians, including neurologists and psychiatrists.

This description is adapted from Supernus SUPN prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

Share this IPO Profile:

IPO Boutique aggregates information on public companies and private companies, such as Supernus SUPN "SUPN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Need a recommendation? Visit our Testimonials page and see over 200 investors singing our praises.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription

© 2005 - 2017 IPO Boutique. All Rights Reserved